|Bid||0.25 x 0|
|Ask||0.28 x 0|
|Day's Range||0.2100 - 0.2500|
|52 Week Range||0.0100 - 4.0000|
|Beta (3Y Monthly)||3.22|
|PE Ratio (TTM)||0.06|
|Earnings Date||May 20, 2016 - May 24, 2016|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.35|
TORONTO, Feb. 11, 2019 -- Asian Mineral Resources Limited (the “Company” or “AMR”) (ASN-TSX Venture) is pleased to announce that it has filed on SEDAR a National Instrument.
Novartis AG and Bayer AG are among more than two dozen major pharmaceutical companies that intend to raise the prices of their drugs in the U.S. in January, Reuters reported late Wednesday. That would end a self-declared freeze on drug price hikes announced last summer, which came after pressure from the Trump administration. Allergan Plc. , GlaxoSmithCline Plc , Amgen Inc. , AstraZeneca Plc. and Biogen Inc. also intend to hike their drug prices, according to documents reviewed by Reuters. In all, nearly 30 drug makers intend to raise prices at the start of the year, the report said. President Donald Trump has vowed to lower the cost of drugs, and earlier this month a number of Congress members challenged drug companies over why they spent large tax savings on buying back stock rather than lowering prices.